Amkor Technology (AMKR) Stock Price Today
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...
Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.
Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...
New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.
Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...
Anthropic's IPO valuation may drop to $1 trillion, shaking AI investment expectations.
Anthropic's anticipated IPO valuation has potentially dropped from $2.5 trillion to around $1 trillion amid a tech selloff and investor pushback. Despite strong revenue growth, the company faces massive future spending commitments and slower growth, ...
Nvidia's 13x earnings multiple may seem cheap but hinges on strong AI growth and upcoming earnings signals.
Nvidia trades at a forward P/E of about 13, appearing cheap given its rapid AI-driven revenue growth, including a 105.8% rise in fiscal Q2 revenue and 117% jump in Data Center sales. However, this valuation depends heavily on continued strong earning...
Rising rates push REITs to discounts; VICI boosts dividend yield with strong AFFO guidance
Rising interest rates have led to significant drops in commercial and equity REIT valuations, creating attractive buying opportunities. BrightSpire Capital has eliminated all its risk-rated five loans and reduced troubled properties, signaling improv...
Three major insurers show strong, durable dividends with low payout ratios and rising investment income.
Travelers, Allstate, and Chubb are three leading NYSE insurance companies known for their reliable dividends. Each pays out a small portion of earnings, allowing steady dividend growth even in tough times. Travelers has raised dividends annually sinc...
Semiconductor sector faces ongoing volatility with sharp recent drops and liquidity pressures expected to ease only briefly in December.
The semiconductor sector, tracked by the SMH ETF, has experienced significant volatility and sharp declines in recent weeks, reflecting broader market weakness with the S&P 500 and NASDAQ 100 also falling. Liquidity pressures in the sector are expect...
Chip stocks plunge on data center fears, but Micron's fundamentals remain strong and valuation attractive.
Chip stocks experienced their worst day since 2020 due to concerns about the data center sector after the election, with major indexes like the VanEck Semiconductor ETF dropping 11.2%. Despite this, Micron Technology's fundamentals appear solid, as m...
US midterm elections shake markets; REITs rally on strong earnings and lower yields
The US midterm elections caused market volatility as Democrats won both Congress chambers, prompting a reassessment of the AI boom. Voters largely opposed data-center expansions, with 40 of 41 measures favoring restrictions. Treasury yields and oil p...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.